Appendix 1: HHS National HIV/AIDS Strategy Implementation Group

Chair

Howard Koh, MD, MPH

Assistant Secretary for Health

Office of the Assistant Secretary for Health

Office of the Secretary

Howard.Koh@hhs.gov

Vice Chair

Ronald O. Valdiserri, MD, MPH

Deputy Assistant Secretary for Health, Infectious Diseases

Office of HIV/AIDS Policy

Office of the Assistant Secretary for Health 

Ron.Valdiserri@hhs.gov

Mayra E. Alvarez, MHA

Director of Public Health Policy

Office of Health Reform

Mayra.Alvarez@hhs.gov

Janet Cleveland

Deputy Director for Prevention Programs

Division of HIV/AIDS Prevention

Centers for Disease Control and Prevention

Jcc9@cdc.gov

Frances E. Ashe-Goins RN, MPH

Acting Director

Office on Women's Health

Frances.Ashe-Goins@hhs.gov

Sonsiere Cobb-Souza

Director, Division of Program Operations

Office of Minority Health 

sonsiere.cobb-souza@hhs.gov

George L. Askew, MD

Senior Advisor to the Deputy Assistant Secretary

Administration for Children and Families 

George.Askew@acf.gov

Sylvie Cohen, MD, MPH 

Director , Medical Employability Program

Office of the Assistant Secretary for Administration 

Sylvie.Cohen@foh.hhs.gov

Jenny Backus

Acting Assistant Secretary for Public Affairs

PDAS for Strategy and Planning

Jenny.Backus@hhs.gov

Rosaly Correa-de-Araujo, MD, MSc, PhD

Deputy Director

Office on Disability

Rosaly.Correa@hhs.gov

Christopher Bates

Executive Director

Presidential Advisory Council on HIV/AIDS

Christopher.Bates@hhs.gov

CDR Gregory Davis

Acting Chief of Staff 

Office of the Surgeon General

Gregory.Davis@hhs.gov

Mary L. Bowers, MSW

Public Health Advisor

Office on Women’s Health

Mary.Bowers@hhs.gov

Carl Dieffenbach, PhD

Director

Division of AIDS

National Institute of Allergy and Infectious Diseases

Carl.Dieffenbach@nih.hhs.gov

Pete Bernardy

Chief, Public Health and Social Services Branch

Office of the Assistant Secretary for 

Financial Resources

Pete.Bernardy@hhs.gov

Daniel Dodgen, PhD

Director

Office of the Assistant Secretary for Preparedness and 

Response

Daniel.Dodgen@hhs.gov

Greg Case

Aging Services Program Specialist

Administration on Aging

Greg.Case@aoa.hhs.gov

Agnes Donahue, DDS, MSD, MPH

Director, Intergovernmental Affairs and Regional Liaison

Office of Assistant Secretary for Health 

Agnes.Donahue@hhs.gov

Laura Cheever, MD, ScM

Deputy Associate Administrator

HIV/AIDS Bureau

Health Resources and Services Administration

Laura.Cheever@hrsa.hhs.gov

Greg Downing

Director

Office of the Assistant Secretary for Planning and Evaluation 

Gregory.Downing@hhs.gov

H. Westley Clark, MD, JD, MPH, CAS, FASAM 

Director, Center for Substance Abuse Treatment

Substance Abuse and Mental Health Services Administration

Westley.Clark@samhsa.hhs.gov

Kevin Fenton, MD, PhD

Director

National Center for HIV/AIDS, Viral Hepatitis, STD and TB 

Prevention, CDC

Kevin.Fenton@cdc.hhs.gov
1

RADM Scott Giberson

USPHS Chief Professional Officer, Pharmacy

U.S. Assistant Surgeon General

HIV/AIDS Program Principal Consultant

Indian Health Service

Scott.Giberson@ihs.gov

Kimberly Konkel

Associate Director for Health 

Center for Faith-Based and Neighborhood Partnerships

Kimberly.konkel@hhs.gov

Garth Graham, MD, MPH 

Deputy Assistant Secretary for Minority Health

Office of Minority Health

Garth.Graham@hhs.gov

Elizabeth Lee

Office of the Assistant Secretary for Legislation

Elizabeth.Lee@hhs.gov

Fred Hellinger, PhD

Senior Economist

Center for Delivery, Organization and Markets

Agency for Healthcare Research and Quality

Fred.Hellinger@ahrq.hhs.gov

Caya B. Lewis, MPH

Chief of Staff

Office of the Administrator, Centers for Medicare & Medicaid 

Services 

Caya.lewis@cms.hhs.gov

Rosie Henson

Senior Advisor to the Assistant Secretary for Health

Office of Public Health and Science

Rosie.Henson@hhs.gov

Jim Mason

Senior Advisor to the Director

Office of Intergovernmental Affairs

James.mason@hhs.gov

Warren W. Hewitt, Jr., MS

Center for Substance Abuse Treatment

Substance Abuse and Mental Health Services Administration

Warren.hewitt@samhsa.hhs.gov 

Jonathan Mermin, MD, MPH

Director, Division of HIV/AIDS Prevention

National Center for HIV/AIDS, Viral Hepatitis, STD and TB 

Prevention, CDC

Jonathan.Mermin@cdc.hhs.gov

Sally Howard

Deputy General Counsel

Office of the General Counsel

Sally.Howard@hhs.gov

Susan Moskosky, MS, RNC

Director, Office of Family Planning

Office of Population Affairs

Susan.moskosky@hhs.gov

David R. Hunt, MD, FACS

Medical Director, Office of Provider Adoption Support

Office of the National Coordinator for Health Information 

Technology

Davidr.Hunt@hhs.gov

Deborah Parham-Hopson, PhD, MSPH, RN

Associate Administrator for HIV/AIDS Bureau

Health Resources Services Administration 

DParham@hrsa.gov

Kenneth D. Johnson 

Senior Civil Rights Analyst

Office for Civil Rights

Kenneth.d.Johnson@hhs.gov

Dalton G. Paxman, PhD

Regional Health Administrator, Region 3

US Public Health Service

Dalton.Paxman@hhs.gov

Evelyn Kappeler

Acting Director 

Office of Adolescent Health

Evelyn.Kappeler@hhs.gov

Angela R. Powell

Bureau of Primary Health Care

Health Resources and Services Administration 

Angela.Powell@hrsa.gov

Marilyn Keefe, MPH

Deputy Assistant Secretary for Population Affairs

Office of Population Affairs

Marilyn.Keefe@hhs.gov

Karen Robinson

Special Assistant to the Chair

Departmental Appeals Board

Karen.robinson@hhs.gov

Alexia Kelley

Director

Center for Faith-Based and Neighborhood Partnerships

alexia.kelley@hhs.gov

David Rutstein

Acting Deputy Surgeon General

Office of the Surgeon General 

David.Rutstein@hhs.gov

Richard M. Klein

Public Health Specialist

Food and Drug Administration

Richard.Klein@fda.gov

RADM Penelope Slade-Sawyer, PT, MSW

Deputy Assistant Secretary for Health

Disease Prevention and Health Promotion

Penelope.Slade-Sawyer@hhs.gov
2

Richard Sorian

Assistant Secretary for Public Affairs

Richard.Sorian@hhs.gov

Wendy Wertheimer

Senior Advisor

NIH Office of AIDS Research

WendyW@nih.gov

Gretchen Stiers

HIV/AIDS Policy Lead, Acting Branch Chief

Division of Policy Innovation

Substance Abuse and Mental Health Services Administration

Gretchen.Stiers@samhsa.gov

Jack Whitescarver, PhD

Director

NIH Office of AIDS Research

Jack.Whitescarver@nih.hhs.gov

Liaison

Gordon Mansergh, PhD

Office of HIV/AIDS Policy

On detail from Division of HIV/AIDS Prevention, CDC

gmansergh@cdc.gov

Liaison

Greg Millett, MPH

Office of National AIDS Policy

The White House

GMillett@who.eop.gov

Liaison

Vera Yakovchenko, MPH

Office of HIV/AIDS Policy

Vera.Yakovchenko@hhs.gov
Appendix 2: HHS Agency/Office Status Report

CDC Activities Due by the End of CY2010:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 1.1 HHS OS/CDC, 

SAMHSA, 

HRSA, and 

HUD

HHS OS will initiate consultations with CDC, SAMHSA, HRSA, HUD, and 

other departments or agencies as appropriate to develop policy 

recommendations for revising funding formulas and policy guidance in order 

to ensure that Federal HIV prevention funding allocations go to the 

jurisdictions with the greatest need.

Initial meeting 11/29/2010.

Goal 1; Step 1.1 CDC CDC will continue to evaluate all existing HIV prevention programs every five 

years to ensure that Federal dollars support programs that are effective and 

have demonstrated improved health outcomes.

Programs are evaluated on an ongoing basis

Goal 1; Step 

1.2.2

CDC CDC will release an update of Act Against AIDS activities and an evaluation 

of successes and challenges.

Report issued in early CY2010

Goal 1; Step 

1.2.4

CDC, SAMHSA CDC and SAMHSA will complete guidance for evidence-based 

comprehensive prevention, including syringe exchange and drug treatment 

programs, for injection drug users.

CDC: Currently finalizing. Expected release by end of 2010/early 

2011

Goal 1; Step 2.1 NIH/CDC NIH and CDC will continue to test mathematical models to explore the best 

combinations of behavioral and biomedical prevention activities.

CDC: Underway

Goal 1; Step 2.3 CDC/SAMHSA CDC and SAMHSA, in consultation with other agencies, will recommend 

necessary elements of comprehensive, evidence-based HIV prevention for 

injection drug using populations.

CDC: Currently finalizing. Expected release by end of 2010/early 

2011

Goal 1; Step 2.4 CDC CDC will work with States and localities to promote and implement scalable 

interventions with individuals living with HIV to lower their risk of transmitting 

HIV.

In January 2011, technical guidance will post on cdc.gov ; there is a 

consultation planned for March 2011; CDC MMWR recommendations 

are anticipated for June 2012

Goal 1; Step 3.1 CDC CDC will initiate a CDC-wide review of all social marketing and education 

campaigns related to HIV, STI, substance abuse and risk behaviors that 

increase risk of HIV transmission and will work to expand evidence based 

efforts to achieve maximum impact.

Initial discussions have occurred.

Goal 1; Step 3.2 CDC CDC will consider strategies for ensuring that school-based health education 

is providing scientifically sound information about HIV transmission and risk 

reduction strategies.

In addition to ongoing support of education agencies to improve their 

capacity to implement effective sexual health education programs, 

CDC School Health Guidelines to Prevent HIV, other STD and 

Pregnancy have been drafted, reviewed by an expert panel 

(September 2010), and will be finalized and released in early 2012

Goal 3; Step 2.2 CDC CDC will identify which States and localities collect CD4 and viral load data. Completed

Goal 3; Step 2.3 HRSA/CDC, 

SAMHSA

HRSA, CDC, and SAMHSA will include language in grant announcements 

requiring the integration of prevention and care services, including referrals to 

clinical services

CDC: Underway
4

CDC Activities Due by the End of CY2011:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 1.2 CDC CDC will establish new standards for reviewing State and local prevention 

plans to ensure that Federal funds are used in a manner addressing people 

living with HIV and reflecting populations with greatest need.

CDC is planning to undertake an evaluation of the community 

planning process to determine how resources are matched to need 

and to incorporate lessons learned from the Enhanced 

Comprehensive HIV Prevention Planning and Implementation 

(ECHPP) project in guidance to sites

Goal 1; Step 1.2 CDC/HRSA, 

SAMHSA, HHS 

OS

CDC in consultation with HRSA, SAMHSA, and HHS OS will develop and 

implement a plan of recommended actions for reducing the proportion of HIVpositive individuals with undiagnosed HIV infection among target populations 

in high prevalence and incidence.

Finalizing Prevention with Positives guidelines

Goal 1; Step 1.2 CDC CDC will update and issue guidelines on the provision of HIV counseling and 

testing in nonclinical settings.

Finalizing Non-Clinical Settings guidelines

Goal 1; Step 1.2 CDC CDC will work with States to ensure that the new guidelines are incorporated 

into State HIV/AIDS plans

Once guidelines are finalized, CDC plans on working with sites to 

incorporate into their HIV/AIDS prevention plans

Goal 1; Step 

1.2.1

CDC CDC will develop recommendations for essential prevention activities and 

services provided to gay and bisexual men as part of the MSM initiative in the 

FY 2011 budget.

CDC is planning to develop safer sex recommendations for MSM and 

continue to work with grantees to improve prevention efforts with 

MSM. Full implementation of the Initiative depends on if it is funded

Goal 1; Step 

1.2.1

CDC CDC will work with States to increase capacity of STD surveillance systems 

to identify gender of sex partners and HIV infection status of men with 

reportable STDs.

CDC collects partner and HIV status information from the majority of 

primary and secondary syphilis cases. In addition, CDC has 

established a sentinel surveillance system (SSuN) to collect this 

information from sentinel clinics for chlamydia and gonorrhea cases. 

CDC Divisions are working together to facilitate sharing of data across 

programs at the state level.

Goal 1; Step 

1.2.1

CDC CDC will expand its work evaluating adaptations of specific interventions for 

transgender populations and issue a fact sheet recommending HIV 

prevention approaches for transgender persons.

Underway

Goal 1; Step 

1.2.1

CDC CDC will work with States to ensure that State plans address deficiencies in 

directing the needed proportion of resources to gay male and transgender 

populations—overall, and within racial/ethnic groups heavily impacted by the 

epidemic.

Underway

Goal 1; Step 

1.2.2

CDC CDC will work with States and localities with implementing the best 

combination of approaches to address HIV and STD prevention among Black 

Americans.

Lessons learned from the ECHPP project will be documented and 

translated

Goal 1; Step 

1.2.3

CDC CDC will launch an evidence-based social marketing campaign targeted to 

the Latino community and will collaborate with national Latino organizations 

on HIV prevention efforts.

Already a focus under Act Against AIDS Leadership Initiative. 

Outreach to national organizations representing Latinos continues

Goal 1; Step 

1.2.3

CDC CDC will release a report on suggestions for border states to help improve 

HIV surveillance and prevention interventions among migrant communities.

CDC Division of HIV/AIDS Prevention is planning to collaborate with 

border states and the CDC Division of Global Migration and 

Quarantine to develop recommendations
5

Goal 1; Step 

1.2.3

CDC CDC will work with States and localities in implementing the best combination 

of approaches to address HIV and STD prevention among Latinos.

Lessons learned from the ECHPP project will be documented and 

translated

Goal 1; Step 

1.2.4

SAMHSA/HUD, 

DOJ, CDC,

HRSA, IHS, 

HHS OS

SAMHSA will work with relevant Federal agencies, HHS OS, States, and 

community-based service providers to implement ways to improve integration 

of substance abuse and mental health screening in programs that serve 

communities with high rates of new HIV infections. These should include risk 

reduction efforts to reduce sexual transmission of HIV among substance 

using populations.

Defer to SAMHSA to report on status

Goal 1; Step 1.3 CDC CDC will provide State health departments with greater concentrations of 

AA/PI or AI/AN populations with recommendations on effective HIV 

surveillance activities for these small populations.

In FY2011, CDC plans to identify strategies to better characterize and 

monitor the epidemic in these populations

Goal 1; Step 1.3 CDC/IHS, HHS 

OS

CDC and IHS will coordinate with HHS OS to consult with tribes to develop 

and implement scalable approaches for effective prevention interventions for 

AI/AN populations that reach those at greatest risk.

Underway

Goal 1; Step 1.3 CDC CDC will work with States with the largest AA/PI communities to implement 

the best combination of approaches to prevent HIV that reach AAPIs at 

greatest risk for infection.

Lessons learned from the ECHPP project will be documented and 

translated

Goal 1; Step 1.4 HHS OS/CDC, 

HRSA, 

SAMHSA, 

OASH, IHS

Relevant HHS agencies will work with States, localities, tribal governments, 

community-based organizations, and evaluation experts to develop standard 

performance measures for HIV prevention programs and provide guidance on 

utilizing these measures.

CDC: Underway

Goal 1; Step 1.4 CDC/SAMHSA CDC will work with SAMHSA to make recommendations for strengthening 

evaluation and aligning [performance] measures and benchmarks across 

programs.

No action yet

Goal 1; Step 1.4 CDC CDC will continue to evaluate the effectiveness of all CDC-funded HIV 

prevention programs to assess their impact on improving health outcomes 

and redirect resources to the most effective programs.

Programs are evaluated on an ongoing basis

Goal 1; Step 2.1 CDC/HRSA, 

SAMHSA

CDC, HRSA, SAMHSA will collaborate with States and localities on pilot 

initiatives for expanding the most promising models for integrating HIV 

testing, outreach, linkage and retention in care in high risk communities.

In FY2011, CDC will continue to fund expanded HIV testing for 

disproportionately affected populations that links people testing 

positive to care

Goal 1; Step 2.1 NIH/CDC NIH will work with CDC to develop and implement a plan for evaluating 

promising community-generated (‘homegrown’) HIV prevention interventions.

Defer to NIH to report on status

Goal 1; Step 2.3 HHS OS/CDC, 

HRSA, 

SAMHSA, NIH, 

CMS

Relevant HHS agencies will make recommendations for scaling up access to 

post exposure prophylaxis (PEP), with priority given to high prevalence 

jurisdictions. Consideration will be given to the role of emergency 

departments (if any), standardized treatment guidelines, and regimen 

selection.

CDC: Lessons learned from the ECHPP project will be documented

Goal 1; Step 2.3 BOP/CDC BOP will expand access to HIV, STD, viral hepatitis screening to prisoners on 

entry, and CDC and BOP will promote risk reduction interventions for healthy 

reintegration of ex-prisoners back into community settings.

Defer to BOP to report on status
6

Goal 1; Step 2.3 HHS OS/CDC, 

HRSA, 

SAMHSA

Relevant HHS agencies will prioritize expanding access to combination 

approaches for HIV prevention, appropriate to epidemic profiles in specific 

localities.

CDC: Lessons learned from the ECHPP project will be documented 

and translated

Goal 1; Step 2.4 CDC CDC will develop recommendations for promoting seroadaptation strategies 

(strategies used by people with HIV to voluntarily adjust their behavior toward 

HIV-negative individuals to lower the risk of transmitting HIV).

Planned

Goal 1; Step 3.1 CDC CDC will work with States and localities to expand public-private partnerships 

to focus on reaching high risk communities and/or the general public to 

prevent HIV/STI infection.

Some planning occurring but expansion will require new resources

Goal 1; Step 3.2 CDC CDC will develop a toolkit and work with States, localities, and school boards 

to implement age-appropriate HIV health education programs.

A compendium of effective school-based interventions is under 

development and expected to be completed in early 2011. In addition, 

an update of the School Health Index, a self-assessment and planning 

guide for schools, that includes HIV and STI prevention will be 

completed in 2011. Finally, revisions to the Health Education 

Curriculum Analysis Tool are drafted and expected to be completed by 

Summer 2011

Goal 1; Step 3.2 CDC CDC will consider potential partnerships, such as with private businesses, to 

expand HIV and STI prevention education.

Some work occurring through CDC’s Business Responds to 

AIDS/Labor Responds to AIDS activities but expansion will require 

new resources

Goal 2; Step 1.1 HRSA/CDC, 

VA, HUD

HRSA in collaboration with CDC, VA, HUD and other relevant agencies will 

develop plans that support health care providers and other staff who deliver 

HIV test results to conduct linkage facilitation to ensure clients access 

appropriate care following a positive diagnosis.

Defer to HRSA to report on status

Goal 2; Step 1.1 CDC, HRSA, 

SAMHSA

CDC, HRSA, SAMHSA and other relevant HHS agencies will work with 

States, tribal governments, localities, and CBOs to promote co-location of 

providers of HIV screening and care services as a means of facilitating 

linkages to care and treatment, and to enhance current referral systems 

within CBOs.

CDC: No action yet

Goal 2; Step 1.2 CDC, SAMHSA, 

DOJ, HUD

HHS OS will work with CDC, SAMHSA, DOJ, and HUD to identify and 

develop potential programs where there can be joint grant awards.

CDC: No action yet

Goal 2; Step 1.3 NIH/CDC, 

HRSA, VA

NIH will work with CDC, HRSA, VA, and other relevant agencies to continue 

to update and disseminate the HHS treatment guidelines.

Defer to NIH to report on status

Goal 3; Step 1.1 VA, CMS, 

HRSA, CDC, 

SAMHSA, NIH

VA, CMS, HRSA, CDC, SAMHSA and NIH will jointly consider and issue a 

report of strategies to encourage providers to collect and report standardized 

viral load and CD4 data from infected individuals within populations at 

greatest risk for HIV infection.

Defer to VA to report on status on overall project. Currently, CDC is 

working to strengthen reporting and use of viral load/CD4 data

Goal 3; Step 2.2 HRSA, CDC HRSA and CDC will convene a consultation with clinical providers and 

community-based organizations to develop recommendations for gathering 

and reporting necessary data to calculate community viral load.

Consultation planned for January 2011. Additional activities will follow

Goal 3; Step 2.2 CDC CDC, in consultation with States, will provide technical assistance to 

localities, particularly those with a heavy disease burden, to collect necessary 

data to calculate community viral load.

Technical assistance will be provided at the HIV Surveillance 

Workshop planned for July 2011.
7

Goal 3; Step 2.3 HHS OS/CDC, 

HRSA, NIH, 

AHRQ

HHS OS will coordinate among HHS agencies to mine existing databases to 

explore associations between HIV infection and social determinants of health.

Defer to HHS to report on status

Goal 3; Step 3.2 HRSA/CDC, 

HHS OS

HRSA, CDC, and HHS OS will develop recommendations for strengthening 

the parity, inclusion, and meaningful representation of people living with HIV 

on planning and priority-setting bodies.

CDC: Planned

Goal 4; Step 2.3 HRSA, 

CDC/HHS OS

HRSA and CDC, and other relevant Federal departments, in coordination with 

HHS OS, will work with States to encourage them to produce annual reports 

on progress made implementing their comprehensive State HIV/AIDS plans 

and that outline successes and challenges in achieving the goals of the 

National HIV/AIDS Strategy.

Defer to HRSA to report on status

HRSA Activities Due by the End of CY2010

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 1.1 HHS OS, CDC, 

SAMHSA, 

HRSA, HUD

HRSA will participate in the consultation with identified Agencies and 

Departments to examine CDC seroprevalence data collected for each city, 

state, and service provider.

HHS OS has lead for HHS; HRSA/HAB leads have been identified: 

Underway

Goal 1; Step 2.4 HRSA HRSA will work with States and localities to ensure that medical provides 

comply with existing HHS treatment guidelines to offer antiretroviral therapy 

to HIV positive clients in care with CD4 up to 500 cells/ml.

HRSA/BPHC will issue a PAL outlining the Bureau’s expectations of 

their funded grantees regarding providing routine HIV testing: 

Completed

HRSA/BPHC will issue a PAL outlining the Bureau’s expectations of 

their funded grantees regarding providing high quality HIV care: 

Planned

All Bureaus within HRSA will include language in all appropriate 

application guidances requiring compliance with PHS HIV Prevention 

and Treatment Guidelines: Underway

HRSA/BPHC will train project officers on PHS HIV treatment 

guidelines and working with grantees to ensure Health Center health 

care plans address guidelines where possible: Planned

HRSA/BCRS will provide information to NHSC clinicians and scholars 

on how to access the PHS HIV Prevention and Treatment Guidelines 

and other related resources on HIV care and treatment: Underway

HRSA will engage with state level grantees in implementation of 

NHAS through meetings and consultations: Planned

HRSA/BPHC will communicate defined roles for PCAs and PCOs in 

implementing NHAS: Planned

PSPC teams to include this quality measure: Planned

Encourage HAB grantees to enroll in PSPC collaborative: Completed
8

Goal 2; Step 1.1 HRSA HRSA will begin to develop information templates to enable health 

departments to provide customized, local information on where to access 

care and support services; such information could be disseminated online at 

community health centers and other facilities. 

HRSA/HAB will implement “Find a provider” on the HAB website. This 

is an electronic template for HAB programs and others that can be 

used to identify HIV care and treatment services available to clients 

who need access to care: Completed

HRSA/HAB will share previously developed grantee resource 

directories for BPHC and HAB funded programs: Completed

HRSA will disseminate information on how to access resource 

directories. Dr. Wakefield to send letter sharing HAB ‘find-the-provider’ 

and BPHC resource directories: Completed

HAB will provide information on available HIV services and BPHC will 

provide information on primary care services in specific jurisdictions: 

Completed

HRSA/BPHC will provide a link on the BPHC website to the HAB 

Target Center, Warmline, and PEPline to facilitate linkages to care: 

Completed

Goal 2; Step 1.3 CMS, HRSA CMS and HRSA will initiate a dialogue on ways to support Medicaid and 

Medicare providers to engage marginalized populations in HIV care.

HRSA Administrator, Dr. Wakefield to meet with CMS Director, Dr. 

Berwick: Completed

Goal 2; Step 2.1 HRSA HRSA will issue guidance encouraging medical, dental, pharmacy, physician 

assistant, nurse practitioner, social work, and nursing schools to implement 

curricula that include HIV-specific training.

HRSA/BHPr will include language in program guidances to encourage 

activities that integrate the NHAS into their programs:

Completed

ORHP will include language in 330A program guidances that 

encourages proposed HIV related activities to be consistent with the 

NHAS: Planned

Create a NHAS PowerPoint presentation for all Project Officers on the 

purpose of the Strategy, components, relevance for BHPr grantees, 

and ways to implement the strategy through grantee activities; 

presentation of the material could take place through a conference 

call, email, or grantee meetings, etc.: Underway

Provide a series of OAA directed NHAS information "TA" conference 

calls or webcasts for grantees; topics will include the purpose of the 

Strategy, components, and relevance to BHPr grantees, including 

ways to implement the strategy through grantee activities: Planned

Explore the Peer to Peer 340B excellence recognition high 

performance site to provide funding stipends to residences: Planned

Goal 2; Step 2.2 HRSA HRSA/HAB created the AIDS AETC multicultural center, a $550,000 

program designed to focus on cultural competency to address highest 

need areas, i.e. providers practicing in underserved areas that do not 

have access to training resources for HIV clinical care: Completed

BPHC will provide a link on its website to the HAB Target Center, 

Warmline, and PEPline to facilitate linkages to care: Completed
9

Goal 3; Step 2.3 HRSA, CDC, 

SAMHSA

HRSA, CDC, and SAMHSA will include language in grant announcements 

requiring the integration of prevention and care services, including referrals to 

clinical services.

All Bureaus in HRSA will include language in all appropriate 

application guidance’s requiring compliance with PHS HIV Prevention 

and Treatment Guidelines: Underway

HRSA/BCRS will provide information to NHSC scholars on how to 

access the PHS HIV Prevention and Treatment Guidelines and other 

related resources on HIV care and treatment: Planned

HRSA/MCHB will provide information on how to access the PHS HIV 

Prevention and Treatment Guidelines and other related resources on 

HIV care and treatment to the State Maternal and Child Health 

Leadership: Planned

HRSA Activities Due by the End of CY2011:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 1.2 CDC/HRSA, 

SAMHSA, HHS 

OS

CDC in consultation with HRSA, SAMHSA, and HHS OS will develop and 

implement a plan of recommended actions for reducing the proportion of HIVpositive individuals with undiagnosed HIV infection among target populations 

in high prevalence and incidence.

HRSA/HAB will participate in CDC consultation when it is scheduled: 

Planned

Establish Performance Improvement Activities (PIA) with Health 

Centers to build/increase their capacity to provide HIV services: 

Planned

Identify Health Centers currently providing Substance Abuse/ 

Behavioral health Services (directly and through referral) and share 

this listing with SAMHSA: Underway

Goal 1; Step 

1.2.4

SAMHSA, HUD, 

DOJ, CDC, 

HRSA, IHS, 

HHS OS

SAMHSA will work with relevant Federal agencies, HHS OS, States, and 

community-based service providers to implement ways to improve integration 

of substance abuse and mental health screening in programs that serve 

communities with high rates of new HIV infections. These should include risk 

reduction efforts to reduce sexual transmission of HIV among substance 

using populations. 

HRSA/HAB - Disseminate the findings from SPNS on substance 

abuse and bupenorphine: Underway

Continue trainings on Mental Health and Substance Abuse to 

providers through the AIDS Education Training Center: Underway

Continue Federal Training Center Collaboration (FTCC) efforts 

between HRSA, SAMHSA, CDC, and OPA: Underway

Goal 1; Step 1.4 HHS OS, CDC, 

HRSA, 

SAMHSA, 

OPHS, IHS

Relevant HHSA agencies will work with States, localities, tribal governments, 

community-based organizations, and evaluation experts, to develop standard 

performance measures for HIV prevention programs and provide guidance on 

utilizing these measures.

Share HRSA performance measures with CDC; CDC to adapt them 

as needed: Completed

Goal 1; Step 2.1 CDC/HRSA, 

SAMHSA

CDC, HRSA, and SAMHSA will collaborate with States and localities on pilot 

initiatives for expanding the most promising models for integrating HIV 

testing, outreach linkage, and retention in care in high risk communities.

Invite SAMHSA, BPHC, BHPr, ORHP to the next Linkage to Care 

SPNS meeting: Planned

Identify large Health Center Controlled Networks (HCCN) that can 

participate in pilot activities regarding EHR and coordination of care 

for patients living with HIV: Underway
10

Goal 1; Step 2.3 HHS OS/CDC, 

HRSA, 

SAMHSA, NIH, 

CMS

Relevant HHS agencies will make recommendations for scaling up access to 

post exposure prophylaxis (PEP), with priority given to high prevalence 

jurisdictions. Consideration will be given to the role of emergency 

departments (if any), standardized treatment guidelines, and regimen 

selection. 

CDC to add money to the Post Exposure Prophylaxis (PEP) program; 

HRSA will ask CDC for funding for the National HIV/AIDS Clinical 

Consultation Center (NCCC) to support TA: No Action Yet

HRSA will participate as implementation actions are scaled up and 

addressed: No Action Yet

Goal 2; Step 1.1 HRSA/CDC, 

VA, HUD

HRSA in collaboration with CDC, VA, HUD, and other relevant agencies will 

develop plans that support health care providers and other staff who deliver 

HIV test results to conduct linkage facilitation to ensure clients access 

appropriate care following a positive diagnosis.

HAB will develop 1-2 best practice documents based on the 

Antiretroviral Treatment Access Study: Planned

HAB will develop a guide on how to link people to care based on the 

SPNS Outreach Initiative: Planned

HAB will provide information from the patient navigator project: No 

Action Yet

BPHC will identify health centers providing HIV testing directly and 

through referral: Completed

HAB will document strategies used to link clients to care/retain clients 

in care: No Action Yet

Start assessing effective practices among RW funded health center in 

12 MSAs: No Action Yet

HAB will provide information to CDC regarding service providers for 

clinics and Ryan White programs that provide treatment on-site 

(through a web link): No Action Yet

BPHC/HAB (Part C Program) will disseminate models of co-located 

services: Planned

SAMHSA has some large sites (use as examples) that offer treatment 

in Mental Health/Substance Abuse treatment sites: Planned

CDC to disseminate testing sites co-located in HIV Specialty Care 

clinics: Planned

Work with States to identify models of co-located HIV screening and 

care sites. HRSA will provide (link to website) information on colocated Community Health Centers and testing sites that provide care 

and treatment: Planned

Goal 2; Step 1.3 NIH/CDC, 

HRSA, VA

NIH will work with CDC, HRSA, VA, and other relevant agencies to continue 

to update and disseminate the HHS treatment guidelines.

HRSA/HAB will continue to serve on the guidelines committee 

disseminating guidelines through the AIDS Education & Training 

Centers: Underway
11

Goal 2; Step 2.1 HRSA HRSA will consider opportunities to foster residency training in HIV 

management and care at community health centers.

Identify academic health centers/clinics serving HIV patients to 

facilitate training and mentorship opportunities for clinicians in health 

centers with limited capacity to provide HIV services: Planned

HAB will provide technical assistance money to fund the development 

of 2-3 teaching health centers: No Action Yet

Develop Peer to Peer network in 340B high performance sites to 

increase placement of residence in HIV programs: No Action Yet

Using the Diabetes self management certification program as an 

example, develop one for HIV: No Action Yet

Goal 2; Step 2.1 HRSA/NIH, 

OMH

HRSA, NIH, and OMH will develop a proposal to fund training programs to 

increase interest, representation, and competence of health professionals, 

researchers, and racial and ethnic minority students in research, public health 

and HIV/AIDS care.

HRSA/BCRS will continue training NHSC clinicians and scholars by:

• Holding a web-based training for NHSC clinicians and/or 

scholars (topics to include HIV testing, care & treatment, etc.)

• Distributing info. and data to clinicians and scholars regarding 

NHAS, HIV prevention, testing and treatment: No Action Yet

Goal 2; Step 2.2 HRSA HRSA will develop a proposal to increase the number of clinical providers 

who are engaged in innovative rural HIV/AIDS health care delivery systems 

(e.g. home healthcare, telehealth).

HAB will disseminate information on the use of telemedicine (i.e. 

Florida AETC): No Action Yet

Develop 2-3 ECHO type programs in AETCs. These could be funded 

by the Secretary’s MAI fund: No Action Yet

Office of Pharmacy Affairs (OPA) to provide model language for 

collaborative practice agreements: No Action Yet

OPA to look into potential workforce study as a part of ACA (section 

5101/5103): No Action Yet

Goal 2; Step 2.2 HRSA HRSA will develop and issue guidance promoting task shifting (transferring 

specific tasks to be performed by physician extenders, such as nurse 

practitioners, or other health workers) and co-management (generalist 

physicians overseeing HIV care while under regular consultation with an HIV 

expert) as methods to improve HIV workforce efficiency.

HAB’s AETC program will document best practices regarding the 

AETC Capacity Building efforts in Health Centers, focusing on roles of 

different providers: Planned

OPA participates in HHS Interagency task force task shifting 

workgroup and will share workgroup products: No Action Yet

Goal 2; Step 2.2 DOL, HRSA DOL and HRSA will work with health professions associations and 

collaborate on workforce training efforts to increase the number of health 

providers who are culturally competent. 

BHPr will look into DOL collaborations: No Action Yet

BPHC will propose activities for PCAs to increase cultural competency 

as part of their Work Force enhancement effort (one of their four top 

priorities): Planned

Goal 2; Step 2.2 HRSA, AHRQ, 

DOL/HHS OS

HRSA, AHRQ, and DOL will coordinate with HHS OS to work with States, 

local governments, and state health professions associations to implement 

their recommendations and guidance to strengthen the current HIV/AIDS 

provider workforce.

BPHC to involve PCAs on workgroup (OPA already works with some 

state PCAs): No Action Yet

HAB - SCSN will require grantees to submit information on workforce 

issues throughout the State: Planned

Goal 2; Step 3.1 AHRQ/HRSA, 

VA, CMS, HHS 

OS

AHRQ, HRSA, VA, and CMS, in coordination with HHS OS will work with 

States, localities, and CBOs to encourage the adoption of nationally accepted 

clinical performance measures to monitor quality of HIV care.

HAB has already created national clinical performance measures to 

monitor the quality of HIV clinical care: Completed

HHS – leads implementation team and will align this goal with Healthy 

People 2020: Planned
12

Goal 3; Step 1.1 VA, CMS, 

HRSA, CDC, 

SAMHSA, NIH

VA, CMS, HRSA, CDC, SAMHSA, and NIH will jointly consider and issue a 

report of strategies to encourage providers to collect and report standardized 

viral load and CD4 data from infected individuals within populations at 

greatest risk for HIV infection.

HRSA/CDC will participate in a consultation meeting on monitoring & 

the use of laboratory data reported to HIV surveillance; HRSA/CDC 

will jointly develop and disseminate a report of successful strategies: 

Planned

BPHC will explore data systems established by Health Center 

Controlled Network grantees to identify any promising strategies for 

collecting, aggregating, and reporting HIV/AIDS related data within 

health centers: No Action Yet

Goal 3; Step 2.2 HRSA, CDC HRSA and CDC will convene a consultation with clinical providers and 

community-based organizations to develop recommendations for gathering 

and reporting necessary data to calculate community viral load.

HRSA will work with CDC to plan and conduct a consultation meeting 

on monitoring & the use of laboratory data reported to HIV 

surveillance; invite Part A grantee from SF Dept. of Public Health: No 

Action Yet

Goal 3; Step 2.3 HHS OS/CDC, 

HRSA, NIH, 

AHRQ

HHS OS will coordínate among HHS agencies to mine existing databases to 

explore associations between HIV infection and social determinants of health.

HRSA will identify databases and the level of management./unit of 

analysis; HRSA will work with OS to provide a list of databases to 

inform this activity: No Action Yet

Goal 3; Step 3.2 HRSA/CDC, 

HHS OS

HRSA, CDC, and HHS OS will develop recommendations for strengthening 

the parity, inclusion, and meaningful representation of people living with HIV 

on planning and priority-setting bodies.

Include HAB/DSS statutory language regarding this activity; use 

letters from the RW 2000 reauthorization; HAB Cooperative 

Agreements target the use of consumers; explore other HRSA 

advisory committees that could add PLWHAs: Underway

HRSA/BPHC POs will work with health centers to establish 

performance improvement activities to increase representation of 

PLWHAs on health center advisory boards, starting with 12 Cities 

Project, including the rural south: No Action Yet

Include PLWHAs in HRSA’s (OPA) Patient Safety & Clinical Pharmacy 

Services Collaborative (PSPC) Leadership Coordinating Council 

(LCC) & the public-private alliance to support this partnership which 

includes patient and consumer advocates: Planned

Goal 3; Step 3.3 HRSA/HHS The CDC/HRSA HIV/AIDS Advisory Committee will solicit public input and 

make recommendations for normalizing and promoting individuals’ safe, 

voluntary disclosure of their HIV status. HRSA will publish the 

recommendations.

Begin discussion at the HRSA/CDC HIV/AIDS Advisory Committee 

Meeting in November 2010 to establish/accomplish by subcommittee:

Planned

Goal 4; Step 2.3 HRSA, 

CDC/HHS OS

HRSA and CDC, and other relevant Federal departments, in coordination with 

HHS OS, will work with States to encourage them to produce annual reports 

on progress made implementing their comprehensive state HIV/AIDS plans 

that outline successes and challenges in achieving the goals of the National 

HIV/AIDS Strategy.

HAB Administrator will consult with CDC Director: Planned

Office of Regional Operations to identify cross cutting issues that are 

relevant to NHAS: No Action Yet

HAB/DSS to require Part B programs to include a NHAS update in 

annual progress reports: No Action Yet
13

NIH Activities Due by the End of CY2010:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 2.1 NIH/CDC NIH and CDC will continue to test mathematical models to explore the best 

combinations of behavioral and biomedical prevention activities.

Expansion of the programs to solicit these kinds of applications is 

ongoing: Underway

NIH Activities Due by the End of CY2010:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 2.1

NIH/CDC NIH will work with CDC to develop and implement a plan for evaluating 

promising community-generated (‘homegrown’) HIV prevention interventions.

NIH accepts and funds meritorious applications evaluating promising 

prevention strategies. It is the role and responsibility of NIH research 

program staff to provide guidance and assistance to potential 

applicants. Underway. 

Goal 1; Step 2.3 HHS OS/CDC, 

HRSA, 

SAMHSA, NIH, 

CMS

Relevant HHS agencies will make recommendations for scaling up access to 

post exposure prophylaxis (PEP), with priority given to high prevalence 

jurisdictions. Consideration will be given to the role of emergency 

departments (if any), standardized treatment guidelines, and regimen 

selection.

NIH will collaborate with CDC as they develop the guidelines for PEP.

Underway. 

Goal 1; Step 1.3 NIH NIH will continue efforts to investigate new antiretroviral therapies for HIV and 

treatment for its associated conditions that are safer, more effective, more 

tolerable, and more durable, making adherence to medication regimens 

easier for people living with HIV. 

Basic, pre-clinical and clinical research to develop new and safer 

drugs are a high priority for NIH, which is supporting a large portfolio 

of research and new initiatives in this area. Underway. 

Goal 1: Step 1.3 NIH/CDC, 

HRSA, VA

NIH will work with CDC, HRSA, VA, and other relevant agencies to continue 

to update and disseminate the HHS treatment guidelines.

NIH continues to maintain and update the guidelines on an ongoing 

basis and posts them on the aidsinfo.nih.gov website. Underway. 

Goal 2; Step 2.1 HRSA/NIH, 

OMH

HRSA, NIH and OMH will develop a proposal to fund training programs to 

increase interest, representation and competence of health professionals, 

researchers, and racial and ethnic minority students in research, public health 

and HIV/AIDS care.

NIH training is designated to support researchers. NIH supports a 

number of programs that are being redesigned to fit within the tighter 

definitions required by the recent Supreme Court decision. Underway. 

Goal 3; Step 1.1 VA, CMS, 

HRSA, CDC, 

SAMHSA, NIH

VA, CMS, HRSA, CDC, SAMHSA and NIH will jointly consider and issue a 

report of strategies to encourage providers to collect and report standardized 

viral load and CD4 data from infected individuals within populations at 

greatest risk for HIV infection.

The FDA has specific data standards with which all clinical trials 

results must be compliant. NIH is standardizing to the FDA standard 

and urges HHS to have all OPDIVs accept the FDA standards.

Underway. 

Goal 3; Step 2.3 HHS OS/CDC, 

HRSA, NIH, 

AHRQ

HHS OS will coordinate among HHS agencies to mine existing databases to 

explore associations between HIV infection and social determinants of health.

NIH has a number of data sets that are available to participate in this 

exercise. Underway. 
14

IHS Activities Due by the End of CY2010:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step: 1.1 IHS HIV program budget formulation will be generated in partnership with 

implementing sites and coordinated with HHS and the Minority AIDS Initiative 

national-level priorities.

FY2011 Proposal drafts developed 10/10

Goal 1; Step: 1.1 IHS IHS will support 13 urban sites through Urban Indian Health Expanded HIV 

Testing project in providing screening and other services within their capacity.

Ongoing implementation with evaluation commenced August 2010

Goal 1; Step 1.3 IHS Through the National IHS HIV Expanded Testing Initiative, IHS will maintain 

at least 40 screening sites, including Tribes and Tribal organizations, as part 

of a comprehensive public health prevention intervention.

Screening rollout and support is ongoing

Goal 1; Step 2.1 IHS/CDC Three locally-based Effective Behavioral Intervention adaptation and 

evaluation projects will be launched within the IHS Research Program, Native 

American Research Centers for Health (NARCH), for use in other 

communities. This work also supports 2011 activities for Step 1.3 of this goal, 

“develop and implement scalable approaches for effective prevention 

interventions.”

NARCH sites have been awarded and have begun work on EBI 

selection

Goal 2; Step 1.1 IHS Refer to National HIV Expanded Testing Initiative. Maintain at least 40 

screening sites, including Tribes/ Tribal organizations as part of a 

comprehensive public health prevention intervention.

Screening rollout and support is ongoing

Goal 2; Step 1.3 IHS Agency will increase direct site-level capacity through: training of additional 

staff in HIV rapid/conventional testing through partnership with SAMHSA; 

clinical preceptorship training for primary care providers; increasing case 

management of clients; and support to clients of treatment adherence 

behaviors. Dissemination will include the development of linkages to remote 

sites to increase the provision of regular consultation and care continuation to 

clients.

Program is in year 2 of implementation by individual IHS service units 

and dissemination of success to other sites is ongoing

Goal 2; Step 2.1

IHS IHS will provide training and resources to sites on using the Chronic Care 

Model and HIV telehealth network to improve the number of available 

providers in remote, historically underserved communities and to improve 

health outcomes through multidisciplinary teams.

Program is in year 2 of implementation and dissemination of success 

to other sites

Goal 2; Step 3 IHS An IHS service unit will develop and launch a behavioral health services 

integration project to provide comprehensive services to HIV+ clients with 

substance abuse treatment needs.

Lessons learned are being collected for 2012 evaluation

Goal 3: Step 2.1 IHS IHS, in partnership with Tribes through a cooperative agreement established 

programs using community-based models to increase screening, disseminate 

HIV awareness, and address stigma.

Two communities are in year 2 of implementation; two are in year 1
15

IHS Activities Due by the End of CY2011:

Please note: Activities planned for CY2011 are dependent on funding awards from the Minority AIDS Initiative (MAI). Only 0.87% of the IHS HIV budget is acquired at the beginning of each 

fiscal year. Slightly more than 99% of the IHS HIV Program total budget is acquired through MAI funds and is obtained roughly in April or late 3rd quarter of each fiscal year.

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step: 1.1 IHS HIV program budget formulation will be generated in partnership with 

implementing sites and coordinated with HHS and the Minority AIDS Initiative 

national-level priorities. In CY 2011, this will provide continued support for 

participating Urban sites, including engagement in priority-city planning.

FY2012 Proposals will be developed 10/11

Goal 1; Step 1.2 CDC IHS will contribute to the Federal dialogue working to develop and implement a plan 

of recommended actions for reducing the proportion of HIV-positive individuals with 

undiagnosed HIV infection among target populations in high prevalence and 

incidence.

MOU with CDC supports this activity

Goal 1; Step 

1.2.1

IHS IHS will develop enriched media marketing materials to include more focused 

(LGBT, MSM, etc) health promotion messages.

Funding for activity has been allocated; work plan in development

Goal 1; Step 

1.2.4

SAMHSA SAMHSA will work with relevant Federal agencies...to implement ways to 

improve integration of substance abuse and mental health screening in 

programs that serve communities with high rates of new HIV infections. 

These should include risk reduction efforts to reduce sexual transmission of 

HIV among substance using populations. IHS will support two service units in 

enhancing continuity of care (through programmatic and staff expansion) and 

preventing HIV transmission among HIV infected American Indian substance 

abuse patients as well as supporting early intervention/access into care. The 

lessons learned from this work are to be reported to Federal colleagues for 

inclusion in strategy assessments.

Program is in year 2 of implementation by individual IHS service units 

and dissemination of success to other sites is ongoing

Goal 1; Step 1.3 

(a)

IHS CDC and IHS will coordinate with HHS OS to consult with tribes to develop 

and implement scalable approaches for effective prevention interventions for 

AI/AN populations and reach those at greatest risk. The agency will use 

results from the local implementation of screening sites and the Effective 

Behavioral Intervention adaptation work to inform approach 

recommendations.

MOU with CDC supports this activity

Goal 1; Step 1.3 

(b)

IHS IHS will work with community-based organizations to develop mediasupported comprehensive sexual health/HIV Interventions: Tools will be 

designed to: delay sexual initiation, reduce number of sexual partners, and 

increase STD/HIV testing (including tribal clinic locator tools).

Funding is in place and Work plan is in development

Goal 1; Step 1.4 IHS IHS will work with States, localities, tribal governments, community-based 

organizations, and evaluation experts to develop standard performance 

measures for HIV prevention programs and provide guidance on utilizing 

these measures.

Developed GPRA Indicators, Federal HIV Testing Report and 

maintained full engagement with partner/ stakeholders

Goal 1; Step 2.2 IHS, OMH, and 

CDC

1) Adoption of the Integration model of HIV and Viral Hepatitis Testing will 

increase the venues and frequency of screening for both infections. 2) 

Collation and dissemination of screening site results to be routinely reported 

to Federal partners.

Funding is transferred via MOU; final contract is in negotiation
16

Goal 1; Step 3.1 IHS IHS will develop and release a brief video to educate AI/AN people about the 

presence of HIV/AIDS in their communities and stimulate community 

discussion on prevention.

Release date March 2011

Goal 1; Step 3.2 IHS, OMH, and 

CDC

IHS will develop and launch a Native-specific HIV/STD/Hepatitis prevention 

and sexual health curriculum appropriate to middle- and high-school 

audiences.

Funding is awarded and work plan is in development

Goal 4; Step 1.1 IHS IHS will participate in coordinated planning efforts, including local-level input 

and coordination of Federal activities.

Four MOUs with other agencies are in development or signed

Goal 4; Step 2 IHS While appropriately protecting confidentiality, IHS will demonstrate increased 

transparency in program monitoring, implementation evaluation, and reporting 

on progress towards achieving National goals. IHS will continue to facilitate 

and maintain all Memorandums of Agreement between IHS and OMH, CDC, 

HRSA, and SAMHSA.

Reporting cycle has been launched; evaluations are proposed

FDA Activities Due by the End of CY2010:

Goal and Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 2.2 FDA FDA approval of 4th generation HIV diagnostic test to simultaneously detects 

both antigen and antibodies for the Human Immunodeficiency Virus (HIV).

Completed, 6/18/2010

with approval of the ARCHITECT HIV Ag/Ab Combo Assay

OS/Office of Minority Health (OMH) Activities Due by the End of CY2010:

Goal and Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 2; Step 2.1 HRSA, NIH and 

OMH

HRSA, NIH and OMH will develop a proposal to fund training programs to 

increase interest, representation and competence of health professionals, 

researchers and racial and ethnic minority students in research, public health 

and HIV/AIDS care.

Initial meeting held 11/20/10. OMH in collaboration with NCMHD, NIH 

will develop a joint funding announcement to increase representation 

of racial and ethnic minority students in research, public health and 

HIV/AIDS care. OMH in coordination with HRSA will continue efforts to 

increase competence of health professionals and researchers in 

HIV/AIDS care. 

AHRQ Activities Due by the End of CY2010:

Goal and Step Lead or Other 

Agencies (All)

Actions to be Performed Current Status

Goal 2; Step 

2.2.2

AHRQ AHRQ will develop a plan to promote common data collection procedures and 

reporting. AHRQ will employ a collection of experts in HIV clinical care, 

patient safety, and financing of care to develop recommendations to improve 

the consistency, content, and usefulness of HIV-related data collected by 

insurers, clinicians, and policy makers.

This issue will be addressed at a January 2011 meeting.
17

AHRQ Activities Due by the End of CY2011:

Goal and Step Lead or Other 

Agencies (All)

Actions to be Performed Current Status

Goal 2; Step 

2.2.6

HRSA, AHRQ, 

DOL/HHS OS

HRSA, AHRQ, and DOL will coordinate with HHS OS to work with States, 

local governments, and state health professions associations to implement 

their recommendations and guidance to strengthen the current HIV/AIDS 

provider workforce.

The strengthening of the HIV/AIDS provider workforce will be 

addressed at a January 2011 meeting.

OS (OHAP) Activities Due by the End of CY2010:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 1.1 HHS OS/CDC, 

SAMHSA, 

HRSA, and 

HUD

HHS OS will initiate consultations with CDC, SAMHSA, HRSA, HUD, and 

other departments or agencies as appropriate to develop policy 

recommendations for revising funding formulas and policy guidance in order 

to ensure that Federal HIV prevention funding allocations go to the 

jurisdictions with the greatest need.

Initial meeting 11/29/2010.

Goal 1; Step 

1.2.1

HHS OS HHS OS will initiate planning for a consultation with national Lesbian, Gay, 

Bisexual, and Transgender (LGBT) organizations to re-engage LGBT 

community leadership in health promotion.

Small group LGBT consult planning meeting will be 11/9/2010; LGBT 

consult will be Feb 2011.

Goal 1; Step 

1.2.4

SAMHSA/HHS SAMHSA and other relevant HHS agencies will consider guidance requiring 

Federally funded substance abuse and mental health treatment clinics to offer 

voluntary routine HIV testing to their clients.

HHS/OS will make this an element of the NHAS operational plan.

Goal 3; Step 3.1 HHS OS/DOJ, 

DOL

HHS OS, DOJ, and DOL Offices of Faith Based and Community Initiatives 

will develop a plan for engaging more faith leaders to promote nonjudgmental 

support for people living with HIV.

An introductory planning and coordination meeting was held 

10/28/2010.

Goal 3; Step 3.4 DOJ/HHS OS DOJ and HHS OS will enter into a Memorandum of Understanding deferring 

complaints of discrimination on the basis of HIV to the Department of Justice 

for investigation and prosecution.

DOJ contacted Oct 2010 to be discussed at next Fed leads meeting.

Goal 4; Step 1.1 HHS OS/HUD, 

VA, DOL, SSA, 

and DOJ

HHS OS will work with HUD, VA, DOL, SSA, DOJ, and other relevant 

Departments or agencies to establish an ongoing process to discuss 

coordination of planning and services delivery for domestic HIV programs.

An introductory coordination meeting was held 9/21/2010; follow-up 

conference call is scheduled for 11/15/2010.

Goal 4; Step 1.1 HHS OS HHS OS will coordinate National HIV/AIDS Strategy efforts with Healthy 

People 2020, the U.S. Preventive Services Task Force, and the Task Force 

on Community Preventive Services in order to make sure that 

recommendations are aligned across groups to the maximum extent possible.

In Aug 2010, the HP2020 work group on HIV/AIDS objectives 

discussed and reviewed revisions to better align with NHAS targets.

Goal 4; Step 1.3 HHS OS/HUD, 

OMB

HHS OS, HUD, and OMB will convene a working group to consider 

recommendations for streamlining data collection requirements.

Preliminary discussions have occurred. The group will convene 1st

Quarter of 2011.
18

Goal 4; Step 2.1 HHS OS HHS OS will task relevant agencies to assess their programs and report to 

ONAP and OMB, on which programs and initiatives satisfy this requirement, 

as well as those that both do not meet evidence-based criteria and should be 

phased-out and those that may require additional review.

This element is part of the HHS NHAS Operational Plan, the 

document presented here.

OS (OHAP) Activities Due by the End of CY2011:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 1.1

HHS OS

All HHS agencies, as appropriate, will report to the HHS Office of the 

Secretary (OS) on baseline measures for funding allocations for their 

programs.

Initial assessment completed (online report form).

Goal 1; Step 1.1 HHS OS HHS OS and relevant agencies will consult with States and other jurisdictions 

prior to allocating prevention funding to targeted populations and communities 

to ensure coordination of efforts.

Meeting scheduled for 11/29/2010.

Goal 1; Step 1.2 CDC/HRSA, 

SAMHSA, HHS 

OS

CDC in consultation with HRSA, SAMHSA, and HHS OS will develop and 

implement a plan of recommended actions for reducing the proportion of HIVpositive individuals with undiagnosed HIV infection among target populations 

in high prevalence and incidence.

Elements presented in this document (HHS NHAS Operational Plan).

Goal 1; Step 

1.2.1

HHS OS HHS OS will work with Congress to consider revising restrictions in the Public 

Health Service Act that hinder the implementation of scientifically validated

and culturally appropriate HIV prevention services.

No action yet.

Goal 1; Step 

1.2.2

HHS OS HHS OS will complete an initiative to compile and collectively assess all 

effective programs and initiatives for reducing HIV infections among Black 

Americans.

No action yet. To begin 1st Quarter of 2011.

Goal 1; Step 

1.2.4

SAMHSA/HHS 

OS

SAMHSA will consult with the HHS OS on policy recommendations for 

revising funding formulas for State/Territory Substance Abuse Prevention and 

Treatment and Mental Health Block Grants and policy guidance in order to 

ensure that Federal HIV prevention funding allocations follow the epidemic at 

the State and local levels.

Meeting scheduled for 11/29/2010.

Goal 1; Step 1.4 SAMHSA/HUD, 

DOJ, CDC, 

HRSA, IHS, 

HHS OS

SAMHSA will work with relevant Federal agencies, HHS OS, States, and 

community-based service providers to implement ways to improve integration 

of substance abuse and mental health screening in programs that serve 

communities with high rates of new HIV infections. These should include risk 

reduction efforts to reduce sexual transmission of HIV among substance 

using populations.

See 12-Cities Project in this document (HHS NHAS Operational Plan).

Goal 1; Step 1.3 CDC/IHS, HHS 

OS

CDC and IHS will coordinate with HHS OS to consult with tribes to develop 

and implement scalable approaches for effective prevention interventions for 

AI/AN populations that reach those at greatest risk.

Follow-up scheduled for 2nd Quarter of 2011.

Goal 1; Step 1.4 HHS OS/CDC, 

HRSA, 

SAMHSA, 

OASH, IHS

Relevant HHS agencies will work with States, localities, tribal governments, 

community-based organizations, and evaluation experts to develop standard 

performance measures for HIV prevention programs and provide guidance on 

utilizing these measures.

Initial discussions have occurred; no formal action yet.

Goal 1; Step 1.4 HHS OS HHS OS will devise ways to provide incentives to reward high performing 

Federal grantees for delivering effective prevention services.

No action yet.
19

Goal 1; Step 2.3 HHS OS/CDC, 

HRSA, 

SAMHSA, NIH, 

CMS

Relevant HHS agencies will make recommendations for scaling up access to 

post exposure prophylaxis (PEP), with priority given to high prevalence 

jurisdictions. Consideration will be given to the role of emergency 

departments (if any), standardized treatment guidelines, and regimen 

selection.

In progress.

Goal 1; Step 2.3 HHS OS/CDC, 

HRSA, 

SAMHSA

Relevant HHS agencies will prioritize expanding access to combination 

approaches for HIV prevention, appropriate to epidemic profiles in specific 

localities.

Ongoing; part of the HHS NHAS Operational Plan.

Goal 2; Step 1.1 HHS OS/HUD HHS agencies, HUD, and other relevant Federal agencies will develop joint 

strategies to encourage co-location of and enhance availability of HIV-related 

services at housing and other nontraditional HIV care sites.

To be addressed 1st Quarter of 2011.

Goal 2; Step 1.2 HHS OS HHS agencies will develop plans and work with States to implement training 

opportunities for health care providers that will highlight the importance of 

program collaboration and service integration to reduce missed opportunities 

for identifying HIV infection.

In progress.

Goal 2; Step 1.2 CDC, 

SAMHSA, DOJ, 

HUD, HHS OS

HHS OS will work with CDC, SAMHSA, DOJ, and HUD to identify and 

develop potential programs where there can be joint grant awards.

No action yet.

Goal 2; Step 3.1 HRSA, AHRQ, 

DOL/HHS OS

HRSA, AHRQ, and DOL will coordinate with HHS OS to work with States, 

local governments, and state health professions associations to implement 

their recommendations and guidance to strengthen the current HIV/AIDS 

provider workforce.

In progress.

Goal 2; Step 3.1 AHRQ/HRSA, 

VA, CMS, HHS 

OS

AHRQ, HRSA, VA and CMS, in coordination with HHS OS, will work with 

States, localities, and CBOs to encourage the adoption of nationally accepted 

clinical performance measures to monitor quality of HIV care.

An element in this document (HHS NHAS Operational Plan).

Goal 2; Step 3.2 HUD/HHS OS HUD will lead a process with HHS OS and relevant Federal agencies to 

identify ways to collaborate and increase access to nonmedical supportive 

services (e.g., housing, food/nutrition services, transportation) as critical 

elements of an effective HIV care system.

No action yet.

Goal 3; Step 2.1 HHS OS HHS OS will collaborate with HHS agencies to engage in policy research and 

evaluation activities to identify effective prevention approaches to reduce 

disease burden in high prevalence communities.

No action yet.

Goal 3; Step 2.1 HHS OS HHS OS will work with the relevant HHS agencies to consider ways to 

enhance the effectiveness of prevention and care services provided for high 

risk communities, including services provided through the Minority AIDS 

Initiative.

Requested MAI proposals in line with NHAS, particularly re 

addressing of health disparities.

Goal 3; Step 2.2 HHS OS/HUD HHS OS and HUD will explore potential demonstration projects of 

bundled/braided funding across agencies to address HIV and other issues in 

high prevalence communities.

No action yet.

Goal 3; Step 2.3 HHS OS/CDC, 

HRSA, NIH, 

AHRQ

HHS OS will coordinate among HHS agencies to mine existing databases to 

explore associations between HIV infection and social determinants of health.

No action yet.
20

Goal 3; Step 3.1 HHS OS/DOL HHS OS will coordinate with DOL to develop standardized occupational 

guidelines for outreach workers, health educators, hotline operators, peer 

counselors, and testing/counseling personnel.

No action yet.

Goal 3; Step 3.1 DOL/SSA, DOJ, 

HHS OS

DOL, SSA, DOJ, and HHS OS will develop a joint initiative to consider ways 

to help individuals living with HIV access income supports, including job skills 

and employment.

No action yet.

Goal 3; Step 3.2 HRSA/CDC, 

HHS OS

HRSA, CDC, and HHS OS will develop recommendations for strengthening 

the parity, inclusion, and meaningful representation of people living with HIV 

on planning and priority-setting bodies.

Ongoing discussion of how to revise.

Goal 3; Step 3.3 DOJ/HHS OS DOJ and HHS OS will identify a departmental point of contact and provide 

technical assistance resources to States considering changes to HIV criminal 

statutes in order to align laws and policies with public health principles.

No action yet.

Goal 3; Step 3.3 PACHA The Presidential Advisory Council on HIV/AIDS (PACHA) will be tasked with 

developing recommendations for ways to promote and normalize safe and 

voluntary disclosure of HIV status in various contexts and circumstances.

No action yet.

Goal 4; Step 1.1 HHS OS/HUD, 

VA, DOL, SSA, 

and DOJ

HHS OS, HUD, VA, DOL, SSA and DOJ and other relevant agencies will 

produce a joint progress report on HIV/AIDS program collaboration. This 

report will highlight key deliverables, areas for consolidating grant awards, 

successes and current challenges, and proposed measurable outcomes

No action yet. Discussions begin 1st Quarter of 2011.

Goal 4; Step 1.1 HHS OS/HUD HHS OS, HUD, and other relevant agencies will consider ways to work with 

State and local health officials to improve coordination of Federal, state, and 

local programs. States will also be encouraged to submit, in consultation with 

localities and CBOs, to HHS OS progress reports on State HIV/AIDS plans 

and on efforts to improve coordination of Federal, state, and local programs.

Ongoing (12-City Project).

Goal 4; Step 1.1 HHS HHS agencies including CDC, HRSA, and SAMHSA will collaborate to 

examine the use of the same unique identifier across federal reporting to 

allow better coordination at the local, state, and federal levels.)

No action yet.

Goal 4; Step 1.2 HHS OS HHS OS will work with Congress and HHS agencies to shift from AIDS cases 

to HIV infections case reporting as a basis for formula grants for HIV 

prevention and to ensure that resources go to States and localities with the 

greatest need.

Initial meeting schedule for 11/29/2010.

Goal 4; Step 1.3 HHS OS/HUD, 

OMB

HHS OS, HUD, and OMB will consult with State and local health officials and 

consider changes to lessen grantee reporting burden.

Ongoing.

Goal 4; Step 2.1 ONAP/HHS OS ONAP and HHS OS will work with Federal partners to establish a monitoring 

system to evaluate the implementation of the Strategy, its success at 

completing key actions, and demonstration of impact through achieving 

specified targets.

No action yet.

Goal 4; Step 2.2 HHS OS/DOJ, 

DOL, HUD, VA, 

and SSA

HHS OS, DOJ, DOL, HUD, VA, and SSA will submit data, as requested, to 

ONAP on successes and challenges in achieving the goals of the National 

HIV/AIDS Strategy.

No action yet.

Goal 4; Step 2.2 PACHA PACHA will establish a mechanism to monitor progress toward achieving the 

National HIV/AIDS Strategy goals.

Discussions underway.
21

Goal 4; Step 2.2 ONAP/HHS OS Relevant Federal departments and agencies will work with ONAP and HHS 

OS to review progress annually and identify remediation steps (if any) to 

achieve National HIV/AIDS Strategy goals. This will include considering key 

action steps for the coming year.

Planning retreat to be scheduled for 3rd Quarter of 2011.

Goal 4; Step 2.3 HRSA, 

CDC/HHS OS

HRSA and CDC, and other relevant Federal departments, in coordination with 

HHS OS, will work with States to encourage them to produce annual reports 

on progress made implementing their comprehensive State HIV/AIDS plans 

and that outline successes and challenges

Initial discussions completed; ongoing.

Goal 4; Step 2.3 ONAP, HHS OS ONAP, HHS OS, and relevant Federal departments and agencies will review 

progress annually and identify recommended remediation steps (if any) to 

assist States in achieving National HIV/AIDS Strategy goals.

No action yet.

SAMHSA Activities Due by the End of CY2010:

Goal and Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 1.1 HHS OS/CDC, 

SAMHSA, 

HRSA, and 

HUD

HHS OS will initiate consultations with CDC, SAMHSA, HRSA, HUD, and 

other departments or agencies as appropriate to develop policy 

recommendations for revising funding formulas and policy guidance in order 

to ensure that Federal HIV prevention funding allocations go to the 

jurisdictions with the greatest need.

Underway. 

Goal 1; Step 

1.2.4

SAMHSA/HHS SAMHSA and other relevant HHS agencies will consider guidance requiring 

Federally funded substance abuse and mental health treatment clinics to offer 

voluntary routine HIV testing to their clients.

SAMHSA will conduct a needs assessment in 2011 to determine the 

distribution and frequency of HIV testing in SAMHSA funded 

substance and mental health treatment clinics. 

Goal 1; Step 

1.2.4

CDC, SAMHSA CDC and SAMHSA will complete guidance for evidence-based 

comprehensive prevention, including syringe exchange and drug treatment 

programs, for injection drug users.

SAMHSA and CDC issued a joint guidance regarding the use of 

Federal funds for syringe service programs (SSP). With respect to 

drug treatment. SAMHSA is the Departmental repository/authority on 

evidence-based practices for drug abusers, and especially opioid 

injecting drug users (IDUs). SAMHSA will assemble a list of evidence 

based practices which have proven successful in the treatment of 

IDUs and will collaborate with CDC in issuing a joint guidance directed 

to IDUs.

Goal 1; Step 2.3 CDC/SAMHSA CDC and SAMHSA in consultation with other agencies will recommend 

necessary elements of comprehensive, evidence-based HIV prevention for 

injection drug using populations.

Actions 1.2.4 and 2.3 essentially identical actions, aside from the 

reference to SSPs.

Goal 3; Step 2.3 HRSA/CDC, 

SAMHSA

HRSA, CDC, and SAMHSA will include language in grant announcements 

requiring the integration of prevention and care services, including referrals to 

clinical services.

SAMHSA will work with CDC and HRSA to develop common grant 

announcement language requiring integration of HIV prevention, 

substance abuse and mental health treatment and HIV medical care.

SAMHSA Activities Due by the End of CY2011:

Goal/ Step Lead/Other 

Agencies (All)

Actions to be Performed Current Status

Goal 1; Step 1.2 CDC/HRSA, 

SAMHSA, HHS 

CDC in consultation with HRSA, SAMHSA, and HHS OS will develop and 

implement a plan of recommended actions for reducing the proportion of HIVThis action is directly related to the 12 cities/MSAs HIV/AIDS planning and implementation cooperative agreements with the 12 designated 
22

OS positive individuals with undiagnosed HIV infection among target populations 

in high prevalence and incidence.

high prevalence areas. CDC has the lead for this effort and both 

HRSA and SMAHSA are working closely with CDC.

Goal 1; Step 

1.2.4

SAMHSA/HHS 

OS

SAMHSA will consult with the HHS OS on policy recommendations for 

revising funding formulas for State/Territory Substance Abuse Prevention and 

Treatment and Mental Health Block Grants and policy guidance in order to 

ensure that Federal HIV prevention funding allocations follow the epidemic at 

the State and local level

SAMHSA will consult with HHS regarding the question of revising the 

formula for the Substance Abuse Prevention and Treatment and 

Mental Health Block Grants.

Goal 1; Step 

1.2.4

SAMHSA/HUD, 

DOJ, CDC, 

HRSA, IHS, 

HHS OS

SAMHSA will work with relevant Federal agencies, HHS OS, States, and 

community-based service providers to implement ways to improve integration 

of substance abuse and mental health screening in programs that serve 

communities with high rates of new HIV infections. These should include risk 

reduction efforts to reduce sexual transmission of HIV among substance 

using populations.

SAMHSA will collaborate with HRSA, CDC, HUD, HHS and DOJ to 

discuss how to screen for substance abuse and mental health 

disorders in CBO settings including adaptation of SBIRT methods to 

CBOs.

Goal 1; Step 1.4 HHS OS/CDC, 

HRSA, 

SAMHSA, 

OASH, IHS

Relevant HHS agencies will work with States, localities, tribal governments, 

community-based organizations, and evaluation experts to develop standard 

performance measures for HIV prevention programs and provide guidance on 

utilizing these measures.

SAMHSA will collaborate with the relevant HHS agencies in the 

developing a Department-wide guidance on evaluation and 

performance measures and standards.

Goal 1; Step 1.4 CDC/SAMHSA CDC will work with SAMHSA to make recommendations for strengthening 

evaluation and aligning measures and benchmarks across programs.

SAMHSA will collaborate with CDC and other HHS agencies in the 

developing a Department-wide guidance on evaluation and 

performance measures and standards.

Goal 1; Step 2.1 CDC/HRSA,

SAMHSA

CDC, HRSA, SAMHSA will collaborate with States and localities on pilot 

initiatives for expanding the most promising models for integrating HIV 

testing, outreach, linkage and retention in care in high risk communities.

SAMHSA will collaborate with CDC and HRSA on pilot initiatives to 

examine and assess promising models for integrating HIV testing, 

outreach and linkage to and retention HIV care in high risk 

communities. This initiative appears to be similar to the NAIAD Test 

and treat pilot and the NIDA RFA –DA -11-00, Seek, Test Treat and 

Retain: Addressing HIV among vulnerable populations.

Goal 1; Step 2.3 HHSOS/CDC, 

HRSA, 

SAMHSA, NIH, 

CMS

Relevant HHS agencies will make recommendations for scaling up access to 

post exposure prophylaxis (PEP), with priority given to high prevalence 

jurisdictions. Consideration will be given to the role of emergency 

departments (if any), standardized treatment guidelines, and regimen 

selection.

SAMHSA will collaborate with CDC and HRSA to examine post 

exposure prophylaxis and make recommendations to the Department 

regarding its use within the framework of substance abuse and mental 

health treatment.

Goal 1; Step 2.3 HHS OS/CDC, 

HRSA, 

SAMHSA

Relevant HHS agencies will prioritize expanding access to combination 

approaches for HIV prevention, appropriate to epidemic profiles in specific 

localities

In collaboration with CDC and HRSA, SAMHSA will examine how 

braided funding can improve access and the efficiency of services in 

local communities.

Goal 2; Step 1.1 SAMHSA SAMHSA will issue guidance for providers to increase linkages to substance 

abuse treatment and mental health services for people living with HIV and 

offer voluntary routine HIV testing to all persons diagnosed with an STD.

SAMHSA will develop guidance for SAMHSA substance abuse and 

mental health treatment grantees recommending that clients who are 

HIV positive or living with AIDS be given appropriate access and 

referrals to mental health and substance abuse treatment services.

Goal 2; Step 1.1 SAMHSA CDC, HRSA, SAMHSA and other relevant HHS agencies will work with 

States, tribal governments, localities, and CBOs to promote co-location of 

providers of HIV screening and care services as a means of facilitating 

linkages to care and treatment, and to enhance current referral systems 

within CBOs.

SAMHSA will collaborate with HRSA, CDC and other relevant 

agencies to develop a multi-agency braided strategy (as appropriate) 

to improve the efficiency of access to care.

Goal 2; Step 1.2 CDC, SAMHSA, 

DOJ, HUD

HHS OS will work with CDC, SAMHSA, DOJ, and HUD to identify and 

develop potential programs where there can be joint grant awards.

SAMHSA will collaborate with HRSA, CDC and other relevant 

agencies to develop a multi-agency braided strategy (as appropriate)

to improve the efficiency of access to care.
23

Goal 2; Step 3.1 SAMHSA/VA SAMHSA, VA, and other relevant agencies will collaborate and develop 

materials for training health care providers to conduct mental health and 

substance use disorder assessments and treatment referrals as appropriate.

SAMHSA will collaborate with the VA, CDC and HRSA to develop 

training materials for health care providers in screening and 

assessment of mental health and substance abuse disorders including 

the use of the Screening and Brief interventions and treatment 

(SBIRT).

Goal 3; Step 1.1 VA, CMS, 

HRSA, CDC, 

SAMHSA, NIH

VA, CMS, HRSA, CDC, SAMHSA and NIH will jointly consider and issue a 

report of strategies to encourage providers to collect and report standardized 

viral load and CD4 data from infected individuals within populations at 

greatest risk for HIV infection.

Although SAMHSA does not routinely collect CD4 and viral load 

information, SAMHSA will support recommendations to standardize 

viral load and CD4 data collection.

Goal 3; Step 2.3 HRSA/CDC, 

SAMHSA

HRSA, CDC, and SAMHSA will include language in grant announcements 

requiring the integration of prevention and care services, including referrals to 

clinical services.

SAMHSA will collaborate with HRSA, CDC and other relevant 

agencies to develop a multi-agency braided strategy (as appropriate) 

to improve the efficiency of access to care.

Goal 4; Step 1.1 SAMHSA SAMHSA will collect and report to HHS OS (and its agency partners) on how 

States are using Block Grant HIV set aside funding and report it annually to 

HHS and its agency partners.

Under current law, the States are not required to provide SAMHSA 

with a report on how these funds have expended. SAMHSA will 

explore appropriate avenues for how this data could be collected and 

reported.
24

Appendix 3: Glossary of Acronyms

ACA Affordable Care Act

ADAP AIDS Drug Assistance Program, HRSA 

AETC AIDS Education and Training Center(s), HRSA

AHRQ Agency for Healthcare Research and Quality

AI/AN American Indian/Alaska Native 

AIDS Acquired Immune Deficiency Syndrome

A/PI Asian/Pacific Islander 

ASL Assistant Secretary for Legislation, HHS

ASPE Assistant Secretary for Planning and Evaluation, HHS

ATTC Addiction Technology Transfer Center(s), SAMHSA

BCRS Bureau of Clinician Recruitment and Service

BOP Bureau of Prisons, DOJ

BPHC Bureau of Primary Health Care

BHPr Bureau of Health Professionals

CBO Community-Based Organization

CDC Centers for Disease Control and Prevention

CFAR Center(s) for AIDS Research, NIH

CHAT Curbing HIV/AIDS Transmission Among High Risk Youth and Adolescents

CHC Community Health Center(s)

CMS Centers for Medicare and Medicaid Services

CTG Community Transformation Grants

CTN Clinical Trials Network, NIH

CVL Community Viral Load

CY Calendar Year

DASH-ID Deputy Assistant Secretary for Health, Infectious Disease

DEBI Diffusion of Effective Behavioral Interventions, CDC

DOE Department of Education

DOJ Department of Justice

DOL Department of Labor

ECHPP Enhanced Comprehensive HIV Prevention Planning, CDC

EHR Electronic Health Records

FDA Food and Drug Administration 

FOA Funding Opportunity Announcement

FPC Family Planning Clinics

FQHC Federally Qualified Health Center

FTCC Federal Training Centers Collaborative

FY Fiscal Year (October 1 – September 30)

GPRA Government Performance and Results Act

HAART (ART) Highly-Active Anti-Retroviral Therapy 

HAB HIV/AIDS Bureau

NCCC National Center for Cultural Competence

HCCN Health Center Controlled Networks

HHS (DHHS) Department of Health and Human Services 

HIRE Health Improvement for Re-entering Ex-offenders

HIV Human Immunodeficiency Virus

HOPWA Housing Opportunities for Persons with AIDS

HRSA Health Resources and Services Administration

HUD Department of Housing and Urban Development

IDU Injection Drug Use(r) 

IGA Office of Inter-Governmental Affairs

IHS Indian Health Service

L2L Linkage to Life

LGBT Lesbian, Gay, Bisexual, Transgender

MAI Minority AIDS Initiative 
25

MCHB Maternal and Child Health Bureau

MOU Memorandum of Understating

MSA Metropolitan Statistical Area

MSM Men who have Sex with Men 

NARCH Native American Research Centers for Health

NHAS National HIV/AIDS Strategy

NIH National Institutes of Health

OAA Office of the Associate Administrator

OAH Office of Adolescent Health, OS

OASH Office of the Assistant Secretary for Health, HHS

OHAP Office of HIV/AIDS Policy, OS

OMB Office of Management and Budget

OMH Office of Minority Health, OS

ONAP Office of National AIDS Policy, The White House

ONC Office of the National Coordinator for Health Information Technology, OS

OPA Office of Population Affairs, OS

OpDiv Operational Division

ORHP Office of Rural Health Policy

OS Office of the Secretary, HHS

OWH Office on Women’s Health, OS

PACHA Presidential Advisory Council on HIV/AIDS

PAL Program Assistance Letter

PCA Primary Care Association

PCO Primary Care Office

PEP Post-Exposure Prophylaxis

PHS Public Health Service

PIA Performance Improvement Activities

PLWHA People Living With HIV/AIDS

PrEP Pre-Exposure Prophylaxis

PSA Public Service Announcement

PSPC Patient Safety & Clinical Pharmacy Services Collaborative

RRNP Regional Resource Network Program

RW Ryan White CARE Act, HRSA

SAMHSA Substance Abuse and Mental Health Services Administration

SAPTBG Substance Abuse Prevention and Treatment Block Grant

SBIRT Screening, Brief Intervention, and Referral to Treatment

SPNS Special Projects of National Significance

SSA Social Security Administration

SSP Syringe Service Program

STD (STI) Sexually Transmitted Disease (Sexually Transmitted Infection) 

TIP Treatment Improvement Protocol 

VA Department of Veterans Affairs